Article
KHDRBS3 promotes multi-drug resistance and anchorage-independent growth in colorectal cancer.
Cancer science - 1 Mar 2021
Ukai Shoichi, Sakamoto Naoya, Taniyama Daiki, Harada Kenji, Honma Ririno, Maruyama Ryota, Naka Kazuhito, Hinoi Takao, Takakura Yuji, Shimizu Wataru, Ohdan Hideki, Yasui Wataru
Abstract excerpt
5-Fluorouracil (5-FU) is one of the most frequently used pharmacological agents in the treatment of colorectal cancer (CRC). Resistance to chemotherapy is a major cause of treatment failure of CRC, and it is a well known fact that cancer stem cells play a significant role in the acquisition of drug resistance. In this study, we focused on the KHDRBS3 gene that encodes KH RNA Binding Domain Containing, Signal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
